A. Gaggar (Birmingham, United States of America), F. Polverino (Boston, United States of America), S. Chotirmall (Dublin, Ireland), S. Weldon (Belfast, United Kingdom)
Neutrophil degranulation responses in exacerbators and non-exacerbators of COPD
A. Jones, R. Robinson, P. Mohammed, G. Davison, K. Lewis (Aberystwyth, Llanelli, Chatham, Swansea, United Kingdom)
|   |
Validating SIK as a novel COPD target using four different human systems
M. Göransson, U. Hedström, B. Fuchs (Gothenburg, Sweden)
| |
Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid
A. Leclercq, A. Simon, F. Zobairi, F. Toti, L. Kessler, R. Kessler (Strasbourg, Illkirch, France)
| |
LSC 2014 abstract - Expansion of multiple dendritic cell populations in the alveolar parenchyma in patients with COPD
M. Mori, C. Andersson, M. Shikhagaie, A. Bergqvist, C. G. Löfdahl, J. Erjefält (Lund, Sweden)
| |
Multi-analyte profiling of inflammatory markers in COPD sputum
F. Pedersen, G. Lauer, G. Quintini, O. Holz, A. M. Kirsten, H. Magnussen, K. F. Rabe, T. Goldmann, H. Watz (Grosshansdorf, Borstel, Hannover, Germany; Zürich, Switzerland)
| |
Quantitative immunohistochemical differences between catalase and thioredoxin in different anatomic compartments of the lung in severe COPD
D. Popa, G. Lejonberg, J. Erjefält, B. T. Olejnicka (Sundsvall, Trelleborg, Lund, Sweden)
| |
Increased expression of receptor for advanced glycation end products in COPD
M. Tanaka, Y. Ueda, M. Shimazaki, M. Ueno, Y. Machida, N. Motono, K. Usuda, M. Sagawa, T. Sakuma (Uchinada, Japan)
| |
Plasma cytokine levels in non-smoking and smoking patients with COPD
A. Tahanovich, A. Kadushkin (Minsk, Belarus)
| |
Epithelial mesenchymal transition (EMT) is present in both large and small airways of smokers
E. H. Walters, M. Mahmood, S. S. Sohal, A. Hardikar, D. Reid, C. Hunter, D. Knight, K. Muller (Hobart, Brisbane, Callaghan, Australia)
| |
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
S. Tangedal, M. Aanerud, L. Persson, K. A. Brokstad, P. Bakke, T. Eagan (Bergen, Norway)
| |
Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL
E. Papakonstantinou, I. Klagas, S. Batzios, M. Roth, M. Tamm, D. Stolz (Basel, Switzerland; Thessaloniki, Greece)
| |
Humoral immunity parameters in smoking and non-smoking patients with COPD
A. Tahanovich, A. Kadushkin (Minsk, Belarus)
| |
Soluble FasL and Fas+ lymphocytes in peripheral blood of non-smoking patients with COPD
A. Tahanovich, A. Kadushkin (Minsk, Belarus)
| |
Mitochondrial membrane potential in the airway and skeletal muscle compartments of smokers with and without COPD
G. Haji, C. Weigman, M. Patel, D. Mohan, P. Kemp, I. Adcock, F. Chung, M. Polkey (London, United Kingdom)
| |
Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD
S. Leivo-Korpela, L. Lehtimäki, K. Vuolteenaho, R. Nieminen, L. Kööbi, R. Järvenpää, H. Kankaanranta, S. Saarelainen, E. Moilanen (Tampere, Seinäjoki, Finland)
| |
Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients
I. Haaland, M. Aanerud, S. Tangedal, L. J. Persson, P. S. Bakke, T. M. Eagan (Bergen, Norway)
| |
LSC 2014 abstract - Evaluation of paraoxonase1 activity and its relationship to the severity of lung impairment in COPD
B. Menon, V. Dogra, G. Nima (Delhi, India)
| |
Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD
M. Roth, D. Stolz, E. Papakonstantinou, I. Bonovolias, G. Karakiulakis, M. Tamm (Basel, Thessaloniki, Switzerland)
| |
Modulation of neutrophil functionalities by indacaterol and their relevance for chronic lung diseases
M. Bakele, I. Winckler, A. Hector, D. Hartl (Tübingen, Germany)
| |
Development of a myeloid cell-binding adenovirus for the potential gene therapy of alpha-1 anti-trypsin deficiency
M. Buggio, C. Towe, D. T. Curiel (St. Louis, United States Of America)
| |